Abstract
This chapter provides an overview of various theoretical models and genomic research that has been performed to develop a deeper understanding of the symptom experience in individuals with breast cancer. Methods for applying genomics in cancer symptom research, and importantly, integrating omic findings across datasets are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armstrong TS. Symptoms experience: a concept analysis. Oncol Nurs Forum. 2003;30(4):601–6. https://doi.org/10.1188/03.ONF.601-606.
Bender CM, Senuzen Ergun F, Rosenzweig MQ, Cohen SM, Sereika SM. Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs. 2005;28(3):219–25. https://doi.org/10.1097/00002820-200505000-00011.
Brant JM, Beck S, Miaskowski C. Building dynamic models and theories to advance the science of symptom management research. J Adv Nurs. 2009;66(1):228–40. https://doi.org/10.1111/j.1365-2648.2009.05179.x.
Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 2006;33(1):E18–26. https://doi.org/10.1188/06.ONF.E18-E26.
Chan A, Yeo A, Shwe M, Tan CJ, Foo KM, Chu P, Khor CC, Ho HK. An evaluation of DNA methyltransferase 1 (DNMT1) single nucleotide polymorphisms and chemotherapy-associated cognitive impairment: a prospective, longitudinal study. Sci Rep. 2019;9(1):14570. https://doi.org/10.1038/s41598-019-51203-y.
Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payner R, Reuben JM, Wang XS, Lee BN. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97(11):2919–25. https://doi.org/10.1002/cncr.11382.
Danzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012;9(7):414–26. https://doi.org/10.1038/nrclinonc.2012.88.
Dodd M, Janson S, Facione N, Fauceet J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S, Taylor D. Advancing the science of symptom management. J Adv Nurs. 2001;33:668–76. https://doi.org/10.1046/j.1365-2648.2001.01697.x.
Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76–8. https://doi.org/10.1093/jncimonographs/lgh008.
Dodd MJ, Cho MH, Cooper BA, Miaskowski C. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs. 2010;14(1):101–10. https://doi.org/10.1016/j.ejon.2009.09.005.
Dorsey SG, Resnick BM, Renn CL. Precision health: use of omics to optimize self-management of chronic pain in aging. Res Gerontol Nurs. 2018;11:7–13. https://doi.org/10.3928/19404921-20171128-01.
Feinberg AP, Longo JD. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018;378(14):1323–34. https://doi.org/10.1056/NEJMra1402513.
Flowers E, Flentje A, Levine J, Olshen A, Hammer M, Paul S, Conley Y, Miaskowski C, Kober K. A pilot study using a multistaged integrated analysis of gene expression and methylation to evaluate mechanisms for evening fatigue in women who received chemotherapy for breast cancer. Biol Res Nurs. 2019;21(2):142–56.
Fu OS, Crew KD, Jacobson JS, Greenlee H, Yu G, Campbell J, Ortiz Y, Hershman DL. Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Surviv. 2009;3(1):241–50. https://doi.org/10.1007/s11764-009-0100-7.
Gullett JM, Cogen RA, Yang GS, Menzies VS, Fieo RA, Kelly DL, Starkweather AR, Jackson-Cook CK, Lyon DE. Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years. Psychooncology. 2019;28(5):997–1003. https://doi.org/10.1002/pon.5028.
Gwede CK, Small BJ, Munster PN, Andrykowski MA, Jacobsen PB. Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Support Care Cancer. 2008;16(8):925–33. https://doi.org/10.1007/s00520-007-0364-2.
Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12(2):123–37. https://doi.org/10.1016/s0149-7634(88)80004-6.
Henly SJ, Kallas KD, Klatt CM. The notion of time in symptom experiences. Nurs Res. 2003;52(6):410–7. https://doi.org/10.1097/00006199-200311000-00009.
Kim H, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28:270–82. https://doi.org/10.1097/00002820-200507000-00005.
Kim HJ, Barsevick AM, Tulman L. Predictors of the intensity of symptoms in a cluster in patients with breast cancer. J Nurs Scholar. 2009a;41(2):158–65. https://doi.org/10.1111/j.1547-5069.2009.01267.x.
Kim E, Jahan T, Aouizerat BE, Dodd MJ, Cooper BA, Paul SM, West C, Lee K, Swift PS, Wara W, Miaskowski C. Differences in symptom clusters identified using occurrence rates versus symptom severity rating in patients at the end of radiation therapy. Cancer Nurs. 2009b;32(6):429–36. https://doi.org/10.1097/NCC.0b013e3181b046ad.
Kim HJ, Barsevick AM, Fang CY, Miaskowski C. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients. Cancer Nurs. 2012;35:E1–E20. https://doi.org/10.1097/NCC.0b013e318233a811.
Kober KM, Olshen A, Conley YP, Schumacher M, Topp K, Smoot B, Mazor M, Chesney M, Hammer M, Paul SM, Levine JD, Miaskowsk C. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors. Mol Pain. 2018;14:1744806918816462. https://doi.org/10.1177/1744806918816462.
Larson P, Carrieri-Kohlman V, Dodd M, et al. A model for symptom management. The University of California, San Francisco School of Nursing Symptom Management Faculty Group. Image J Nurs Sch. 1994;26(4):272–6.
Lengacher CA, Reich RR, Post-White J, Moscoso M, Shelton MM, Barta M, Le N, Budhrani P. Mindfulness based stress reduction in post-treatment breast cancer patients: an examination of symptoms and symptom clusters. J Behav Med. 2012;35:86–94. https://doi.org/10.1007/s10865-011-9346-4.
Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19(3):14–27. https://doi.org/10.1097/00012272-199703000-00003.
Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16:143–63. https://doi.org/10.1007/BF01173486.
Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Robins Sadler G, Dimsdale JE, Rissling M, He F, Ancoli-Israel S. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 2009;18(2):187–94. https://doi.org/10.1002/pon.1412.
Low SK, Zembutsu H, Nakamura Y. Breast cancer: the translation of big genomic data to cancer precision medicine. Cancer Sci. 2018;109:497–506. https://doi.org/10.1111/cas.13463.
Lyon D, Elmore L, Aboalela N, Merrill-Schools J, McCain N, Starkweather A, Elswick RK Jr, Jackson-Cook C. Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis. Biol Res Nurs. 2014;16(2):160–74. https://doi.org/10.1177/1099800413483545.
McCall MK, Connolly M, Nugent B, Conley YP, Bender CM, Rosenzweig MQ. Symptom experience, management, and outcomes according to race and social determinants including genomics, epigenomics, and metabolomics (SEMOARS + GEM): an explanatory model for breast cancer treatment disparity. J Cancer Educ, 2019. https://doi.org/10.1007/s13187-019-01571-w.
Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr. 2004;32:17–21. https://doi.org/10.1093/jncimonographs/lgh023.
Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, West C, Cho M, Bank A. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33(5):E79–89. https://doi.org/10.1188/06.ONF.E79-E89.
Miaskowski C, Cooper BA, Melisko M, Chen LM, Mastick J, West C, Paul SM, Dunn LB, Schmidt BL, Hammer M, Cartwright F, Wright F, Langford DJ, Lee K, Aouizerat BE. Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer. 2014;120:2371–8. https://doi.org/10.1002/cncr.28699.
Mogil JS. Pain genetics: past, present and future. Trends Genet. 2012;28:258–66. https://doi.org/10.1016/j.tig.2012.02.004.
National Institutes of Health, National Institute of Nursing Research. Symptom science. Bethesda: National Institutes of Health; 2013. Retrieved from https://www.ninr.nih.gov/newsandinformation/iq/symptom-science-workshop.
Palesh OG, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis ML, Butler LD, Carlson R, Spiegel D. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2007;75(1):37–44. https://doi.org/10.1016/j.biopsycho.2006.11.002.
Richardson LC, Henley SJ, Miller JW, Massetti G, Thomas CC. Patterns and trends in age-specific black-white differences in breast cancer incidence and mortality – United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2016;65:1093–8. https://doi.org/10.15585/mmwr.mm6540a1.
Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer. 2002;10(4):329–36. https://doi.org/10.1007/s00520-001-0317-0.
So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M, Li GK. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum. 2009;36(4):E205–14. https://doi.org/10.1188/09.ONF.E205-E214.
Starkweather AR, Lyon DE, Elswick RK Jr, Montpetit AJ, Conley Y, McCain NL. A conceptual model of psychoneurological symptom cluster variation in women with breast cancer: bringing nursing research to personalized medicine. Curr Pharmacogenomics Pers Med. 2013;11:224–30. https://doi.org/10.2174/18756921113119990004.
Teel CS, Meek P, McNamara AM, Watson L. Perspectives unifying symptom interpretation. Image J Nurs Sch. 1997;29(2):175–81. https://doi.org/10.1111/j.1547-5069.1997.tb01553.x.
Yang GS, Kim HJ, Griffith KA, Zhu S, Dorsey SG, Renn CL. Interventions for the treatment of aromatase inhibitor-associated arthralgia in breast cancer survivors: a systematic review and meta-analysis. Cancer Nurs. 2017;40(4):E26–41. https://doi.org/10.1097/NCC.0000000000000409.
Yang GS, Barnes NM, Lyon DE, Dorsey SG. Genetic variants associated with cancer pain and response to opioid analgesics: implications for precision pain management. Semin Oncol Nurs. 2019a;35(1):291–9. https://doi.org/10.1016/j.soncn.2019.04.011.
Yang GS, Kumar S, Dorsey SG, Starkweather AR, Kelly DL, Lyon DE. Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors. Support Care Cancer. 2019b;27(2):351–71. https://doi.org/10.1007/s00520-018-4508-3.
Yang GS, Mi X, Jackson-Cook CK, Starkweather AR, Lynch Kelley D, Archer KJ, Zou F, Lyon DE. Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year. Epigenetics. 2019c;18:1–12. https://doi.org/10.1080/15592294.2019.1699695.
Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. Clin Epigenetics. 2019;11(1):45. https://doi.org/10.1186/s13148-019-0641-1.
Zorina-Lichtenwalter K, Meloto CB, Khoury S, Diatchenko L. Genetic predictors of human chronic pain conditions. Neuroscience. 2016;338:36–62. https://doi.org/10.1016/j.neuroscience.2016.04.041.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Starkweather, A.R., Yang, G.S., Kelly, D.L., Lyon, D.E. (2020). Genomics of Breast Cancer and Treatment-Related Pain and Comorbid Symptoms. In: Dorsey, S., Starkweather, A. (eds) Genomics of Pain and Co-Morbid Symptoms. Springer, Cham. https://doi.org/10.1007/978-3-030-21657-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-21657-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21656-6
Online ISBN: 978-3-030-21657-3
eBook Packages: MedicineMedicine (R0)